Your browser doesn't support javascript.
loading
Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.
Heald, Alison E; Iversen, Patrick L; Saoud, Jay B; Sazani, Peter; Charleston, Jay S; Axtelle, Tim; Wong, Michael; Smith, William B; Vutikullird, Apinya; Kaye, Edward.
Afiliação
  • Heald AE; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA healda@uw.edu.
  • Iversen PL; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA Oregon State University, Corvallis, Oregon, USA.
  • Saoud JB; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Sazani P; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Charleston JS; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Axtelle T; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Wong M; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
  • Smith WB; New Orleans Center for Clinical Research-Knoxville, Knoxville, Tennessee, USA.
  • Vutikullird A; West Coast Clinical Trials, Cypress, California, USA.
  • Kaye E; Sarepta Therapeutics, Inc., Cambridge, Massachusetts, USA.
Antimicrob Agents Chemother ; 58(11): 6639-47, 2014 Nov.
Article em En | MEDLINE | ID: mdl-25155593

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Morfolinos / Doença do Vírus de Marburg Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença pelo Vírus Ebola / Morfolinos / Doença do Vírus de Marburg Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article